SpineGuard is a public company listed on the NYSE Alternext (ticker: ALSGD) in Paris since April 29, 2013. Pierre Jérôme and Stéphane Bette founded the company in January 2009 with the aim to fully exploit the great clinical and market potential of PediGuard, the first and only handheld device capable of alerting surgeons in real time to potential pedicular or vertebral breaches.Omnes Capital, IPSA, A Plus Finance and Delta Partners are the four historical financial investors of the company.The corporate headquarters of SpineGuard are located in Vincennes, near Paris, France. SpineGuard also has an office in San Francisco focused on sales and marketing to support the technology and the products in the US market.
Pedicle screw-based stabilization has become the gold standard for treating spinal instabilities and deformities. Nearly one million spine procedures using pedicle screws are estimated to be performed annually worldwide (I-Data research). Technological advancements such as minimally invasive surgery, bone substitutes, dynamic stabilization and thoracic screws further reiterate the importance of pedicle screw placement in spine surgery. However, accuracy of pedicle screw placement remains a critical issue:
According to the latest scientific papers (ref: SpineGuard’s clinical brochure), around 20% of pedicle screws using conventional techniques have been reported as misplaced and around 5% of patients have complications related to misplaced screws requiring a revision surgery.
With growing clinical evidence confirming its efficacy, the DSG technology is emerging as the most compelling answer to the clinical needs associated with pedicle screw placement. Close to 80,000 procedures have been performed worldwide with the PediGuard devices.
The summary of SpineGuard’s comprehensive compliance program is available upon request. Please e-mail info@spineguard.com for more information. http://www.spineguard.com